
POLXF
Healthcare · Biotechnology · $6.8M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Sep 14, 2023 | Time not confirmed | — | 0.00 | — |
| May 1, 2023 | Time not confirmed | — | -0.04 | — |
| Dec 15, 2022 | Time not confirmed | — | -0.11 | — |
| Sep 15, 2022 | Time not confirmed | — | 0.00 | — |
| May 2, 2022 | Time not confirmed | — | 0.00 | — |
| Dec 15, 2021 | Time not confirmed | — | -0.02 | — |
| Sep 15, 2021 | Time not confirmed | — | -0.01 | — |
| Jun 15, 2021 | Time not confirmed | — | -0.06 | — |
| Apr 30, 2021 | Time not confirmed | — | 0.02 | — |
| Dec 15, 2020 | Time not confirmed | — | 0.01 | — |
| Sep 15, 2020 | Time not confirmed | — | 0.02 | — |
| Jun 15, 2020 | Time not confirmed | — | 0.02 | — |
| Apr 30, 2020 | Time not confirmed | — | -0.04 | — |
Polydex Pharmaceuticals Limited, through its subsidiaries, develops, manufactures, and markets biotechnology-based products for the human pharmaceutical market worldwide. The company also manufactures bulk pharmaceutical intermediates for the veterinary pharmaceutical industry. It primarily offers dextran and derivative products, including iron dextran, a derivative of dextran that is injected into pigs at birth as…
| Time not confirmed |
| — |
| 0.02 |
| — |
| Sep 16, 2019 | Time not confirmed | — | 0.03 | — |
| Apr 30, 2019 | Time not confirmed | 0.00 | 0.06 | — |
| Dec 14, 2018 | Time not confirmed | — | 0.01 | — |
| Sep 14, 2018 | Time not confirmed | — | 0.02 | — |
| Jun 14, 2018 | Time not confirmed | — | 0.03 | — |
| Mar 28, 2018 | Time not confirmed | — | 0.02 | — |